Citi Upgrades Hologic (HOLX) to Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Citi Upgrades Hologic (HOLX) to Buy

Citi Downgrades Bio-Rad Labs (BIO) to Neutral

April 3, 2024 5:39 AM EDT

Citi analyst Patrick Donnelly downgraded Bio-Rad Labs (NYSE: BIO) from Buy to Neutral with a price target of $365.00 (from $400.00).

The analyst comments "We downgrade BIO to Neutral (TP $365) and upgrade HOLX to Buy (TP $95) and SHC to Buy/HR (TP $16). For BIO, visibility remains limited on the ability to achieve its Life... More